報價延遲最少15分鐘:2025/01/21 05:33 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.9601 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.46/-1.97
|
|
企業價值
2.36M
|
| 資產負債 |
|
每股賬面淨值
1.54
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 05:33 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. |